J C Fernandes Selected Research

J C Fernandes Research Topics

6	Osteoarthritis 01/2004 - 06/2000
3	Psoriasis (Pustulosis Palmaris et Plantaris) 04/2013 - 07/2006
2	Osteoporosis 10/2013 - 09/2009
2	Necrosis 04/2013 - 03/2013
1	Inflammation (Inflammations) 01/2014
1	Anemia 01/2014
1	Acne Vulgaris 03/2013
1	Hutchinson's Melanotic Freckle (Lentigo Maligna) 10/2009
1	Osteoporotic Fractures 09/2009
1	Osteolysis 11/2002
1	Cardiac Arrhythmias (Arrythmia) 05/2001
1	Laryngitis 05/2001
1	Sclerosis 04/2001
1	Osteophyte 12/2000

2	Dexamethasone (Maxidex)FDA LinkGeneric 10/2013 - 05/2001
2	licofeloneIBA 01/2004 - 10/2001
2	Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA 01/2004 - 10/2001
2	CytokinesIBA 11/2002 - 10/2000
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 11/2001 - 06/2000
1	AntibodiesIBA 01/2014
1	HepcidinsIBA 01/2014
1	IronIBA 01/2014
1	beta CateninIBA 10/2013
1	CCAAT-Enhancer-Binding Protein-alphaIBA 10/2013
1	GlucocorticoidsIBA 10/2013
1	Ficusin (Psoralen)IBA 04/2013
1	Acitretin FDA Link 04/2013
1	Isotretinoin (Accutane)FDA LinkGeneric 03/2013
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 03/2013
1	Imiquimod (Aldara)FDA LinkGeneric 10/2009
1	Alendronate (Alendronate Sodium)FDA LinkGeneric 09/2009
1	Risedronic Acid (Actonel)FDA LinkGeneric 09/2009
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 07/2006
1	Cyclooxygenase InhibitorsIBA 01/2004
1	ProstaglandinsIBA 11/2002
1	Prostaglandins EIBA 11/2002
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 11/2001
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 11/2001
1	Lipoxygenase (Lipoxygenase-1)IBA 10/2001
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 10/2001
1	Interleukin-1beta (Interleukin 1 beta)IBA 10/2001
1	collagenase 1IBA 10/2001
1	Epinephrine (Adrenaline)FDA LinkGeneric 05/2001
1	Insulin-Like Growth Factor I (IGF-1)IBA 04/2001
1	Dinoprostone (PGE2)FDA Link 04/2001
1	Parathyroid Hormone (Parathormone)IBA 04/2001
1	carprofen FDA Link 12/2000
1	Lysine (L-Lysine)FDA Link 06/2000
1	Proteins (Proteins, Gene)FDA Link 06/2000
1	Caspase 3 (Caspase-3)IBA 06/2000

3	Therapeutics 10/2013 - 07/2006